Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma
Status:
Terminated
Trial end date:
2018-04-04
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if loratadine can control bone pain
caused by pegfilgrastim (a drug given after chemotherapy to help raise white blood cell
counts).